JOY ARTIN; YUMN A. ELSABAGH; LAILA RASHED; MOHAMED A. HUSSEIN. Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations. Archives of Rheumatology, [S. l.], v. 38, n. 2, p. 249–256, 2023. DOI: 10.46497/ArchRheumatol.2023.9638. Disponível em: http://anadolupsikiyatri.net/index.php/pub/article/view/1337. Acesso em: 3 oct. 2025.